Sun upbeat on late-stage Merck psoriasis asset amid strong Q2
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries has reported a 15% increase in net profits at Rs15.72bn ($256m) for the second quarter ended September 2014, backed by a strong showing in the US and India. Revenues for the quarter increased to INR47.51bn (+13%).